1-2 of 2
Dan A. Erkes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Activation of CD8+ T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors

Free
Jessica L.F. Teh, Dan A. Erkes, Phil F. Cheng, Manoela Tiago, Nicole A. Wilski, Conroy O. Field, Inna Chervoneva, Mitch P. Levesque, Xiaowei Xu, Reinhard Dummer, Andrew E. Aplin
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (9): 1114–1121.
https://doi.org/10.1158/2326-6066.CIR-19-0743
Published: 01 September 2020
View articletitled, Activation of CD8+ T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors
Open the PDF for Activation of CD8+ T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors in another window
Includes: Supplementary data
Journal Articles

Abstract A33: The next-generation BET inhibitor, PLX51107, delays melanoma growth, altering the tumor immune microenvironment via Cox2 inhibition

Free
Dan A. Erkes, Conroy O. Field, Claudia Capparelli, Manoela Tiago, Timothy J. Purwin, Shea A. Heilman, Inna Chervoneva, Adam C. Berger, Sheera R. Rosenbaum, Edward J. Hartsough, Jessie Villanueva, Andrew E. Aplin
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (4_Supplement): A33.
https://doi.org/10.1158/2326-6074.TUMIMM18-A33
Published: 01 April 2020
View articletitled, Abstract A33: The next-generation BET inhibitor, PLX51107, delays melanoma growth, altering the tumor immune microenvironment via Cox2 inhibition